Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion type Assertion NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_head.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion description "[We investigated effects of EGFR and HER-2 blockade in colon cancer cell lines using cetuximab and trastuzumab, with the aim of developing novel approaches to cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_provenance.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion evidence source_evidence_literature NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_provenance.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion SIO_000772 25131935 NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_provenance.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion wasDerivedFrom befree-2016 NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_provenance.
- NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_assertion wasGeneratedBy ECO_0000203 NP1211491.RAPWV8A4zNmfJvX2UGhz2A3YLNic3jOCLf-xPjK23akNQ130_provenance.